Older Adults’ Attitudes Toward Deprescribing in 14 Countries

JAMA Network Open, Journal Year: 2025, Volume and Issue: 8(2), P. e2457498 - e2457498

Published: Feb. 10, 2025

Importance Better understanding of patients’ attitudes toward deprescribing specific medications will inform future interventions. Objective To investigate older adults’ by investigating which they would like to have deprescribed, the reasons why, and patient factors associated with interest in deprescribing. Design, Setting, Participants This survey study was conducted from May 2022 December 2023 primary care settings 14 countries. Patients aged 65 years or taking 5 more were consecutively recruited their general practitioner (GP) completed questionnaire. Exposures Patient characteristics, including gender, number medications, GP education level, financial status, confidence completing medical forms, self-rated health, satisfaction trust GP, country. Main Outcomes Measures The outcomes as measured responses question, “Thinking about your current medication list, are there any that you stop reduce dose of?” Multilevel multivariable logistic regression analysis used, adjusted for clustering effect at country association between characteristics Results Of 1340 patients (mean [SD], 96 [47] per country), 736 (55%) women, 580 (44%) had secondary school highest level education, 1089 (82%) satisfied 589 expressed deprescribe 1 medications. varying levels, 79% (86 109 patients) Poland 23% (21 Bulgaria. 3 most reported deprescribed diuretics (111 1002 [11%]), lipid-modifying agents (109 acting on renin-angiotensin system (83 [8%]). odds naming least lower higher (odds ratio, 0.31; 95% CI, 0.21-0.47) 0.960; 0.930-0.998). Conclusions Relevance In this older, varied across countries, demonstrating interventions could be impactful when adapted contexts. These findings highlight importance patient-practitioner communication ensuring appropriate use.

Language: Английский

---

Attitudes of Australian patients receiving inpatient mental health care towards deprescribing: a cross-sectional survey

BMC Psychiatry, Journal Year: 2025, Volume and Issue: 25(1)

Published: March 21, 2025

Abstract Background Psychotropic polypharmacy is common, increasing, and associated with higher risks of adverse effects, hospitalisations mortality. This study aimed to explore the attitudes beliefs people receiving inpatient mental health care toward deprescribing ( discontinuing a medication when current or potential risk outweighs benefit ) determine any patient characteristics these beliefs. Methods A cross-sectional survey patients admitted two open acute psychiatric units was conducted over 6-month period in Australian metropolitan city Adelaide. Individuals were eligible participate regardless their reason for admission, if they at least 18 years old able converse, read write English, provide informed consent. Participant responses validated revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire collected. The rPATD includes questions grouped into four factors: (i) perceived burden medications, (ii) involvement management, (iii) belief appropriateness (iv) concerns about stopping, plus global questions. Participants encouraged think medications that use conditions completing questionnaire. Results One hundred participants recruited, mean age 41.6 (SD = 13.7). 65% agreed would be willing stop one more psychotropic doctor said it possible. In binary logistic regression model, willingness have deprescribed mostly strongly predicted by Involvement factor score (odds ratio [OR] 5.92, 95% confidence interval [CI] 2.10-15-16.70, p < 0.001). Conclusions majority having deprescribed. When medically justified, professionals should feel comfortable initiating conversations understand preferences, fostering shared decision-making management. Clinical trial number Not applicable.

Language: Английский

---

General polypharmacy, psychotropic polypharmacy, attitudes of patients on psychotropic deprescribing, and associated factors in adult psychiatric outpatients: a survey study in a comprehensive specialized hospital, northwest Ethiopia

BMC Psychiatry, Journal Year: 2025, Volume and Issue: 25(1)

Published: April 8, 2025

Language: Английский

---

Advancing deprescribing: Learnings from the first international conference on deprescribing

Basic & Clinical Pharmacology & Toxicology, Journal Year: 2023, Volume and Issue: 134(1), P. 3 - 5

Published: Nov. 21, 2023

There are no conflicts to declare. Research data not shared.

Language: Английский

---

Polypharmazie

Elsevier eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 131 - 138

Published: Dec. 5, 2024

---